Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Nov. 30, 2021
Nov. 30, 2020
CURRENT ASSETS    
Cash and cash equivalents $ 56,308 $ 3,175
Restricted cash 92 6,389
Accounts receivable, net 1,658 834
Inventory, net 6,613 4,817
Prepaid expenses and other current assets 1,490 1,391
Total current assets 66,161 16,606
Patent rights, net 3,668 811
Deposits for equipment 1,293 619
Right-of-use-asset, net 1,086 1,200
Property and equipment, net 1,972 1,220
Goodwill 816 651
Restricted cash 0 92
Other assets 318 17
TOTAL ASSETS 75,314 21,216
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 6,996 6,629
Operating lease liabilities, current 463 257
Deferred revenue 720 4,843
Notes payable, current 0 76
Total current liabilities 8,179 11,805
Notes payable, non-current 0 115
Deferred revenue, non-current 405 59
Operating lease liabilities, non-current 632 828
Total Liabilities 9,216 12,807
COMMITMENTS AND CONTINGENCIES (NOTE 20)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued 0 0
Common stock, $0.001 par value 300,000,000 shares authorized, 23,754,096 and 14,852,023 shares issued and outstanding, respectively 23 15
Additional paid-in capital 119,589 58,581
Accumulated deficit (53,498) (50,215)
Accumulated other comprehensive (loss) income (16) 28
Total Stockholders’ Equity 66,098 8,409
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 75,314 21,216
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued $ 0 $ 0